| Stock Name | Dynavax Technologies Corporation |
| Ticker | DVAX(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US2681582019 |
| LEI | 549300T5URIXWDILX594 |
| Date | ETF ISIN/Name | Num Shares | Book value |
|---|---|---|---|
| 2025-10-23 | IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) | 96,498 | USD 983,315 0.4% |
| 2025-10-23 | IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) | 132,990 | USD 1,355,168 0.4% |
| 2025-10-23 | IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc)) | 146,777 | USD 1,495,658 0.4% |
| 2025-10-23 | IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) | 73,378 | USD 747,722 0.4% |
| 2025-10-23 | IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) | 73,378 | USD 747,722 0.4% |
| 2025-10-23 | IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) | 9,170 | USD 93,442 0.4% |
| Total = | 532,191 | USD 5,423,027 | |